Limited Competition for the Continuation of Clinical Centers to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis Consortium (U01 Clinical Trial Optional)
ID: RFA-DK-20-504 • Type: Posted
Opportunity Assistant
Loading
Overview
Category of Funding
Food and Nutrition
Health
Health
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 9/24/20 the National Institutes of Health posted grant opportunity RFA-DK-20-504 for Limited Competition for the Continuation of Clinical Centers to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis Consortium (U01 Clinical Trial Optional).
The grant will be issued under grant program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
Timing
Posted Date
Sept. 24, 2020, 12:00 a.m. EDT
Closing Date
Dec. 16, 2020, 12:00 a.m. EST Past Due
Last Updated
Sept. 25, 2020, 11:51 a.m. EDT
Version
1
Archive Date
Jan. 21, 2021
Eligibility
Eligible Applicants
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Info
Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Award Sizing
Ceiling
$250,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 402-2541
Additional Information Site